BiotechTube
Home/EmeraMed/Paul Reicherter, MD
PR

Paul Reicherter, MD

Board Member

EmeraMed

Therapeutic Areas

Heavy Metal ToxicityCOPDInfectious Disease

EmeraMed Pipeline

DrugIndicationPhase
Emeramide for Mercury ToxicityMercury PoisoningPhase 2
Emeramide for COPDChronic Obstructive Pulmonary DiseasePhase 2
Emeramide for COVID-19COVID-19Preclinical

Leadership Team at EmeraMed

BH
Boyd Haley, PhD
Chief Scientist & CEO
RK
Ragnar Klingberg
Board Member
KW
Kathryn Wachsman
Board Secretary
View full EmeraMed profile